Publications

5813 Results

Predictive Role of Circulating Tumor DNA in Stage III Colon Cancer Treated With Celecoxib: A Post Hoc Analysis of the CALGB (Alliance)/SWOG 80702 Phase 3 Randomized Clinical Trial

Authors
Zhang GQ
Journal / Conference
JAMA Oncol. 2025 Dec 4:e255144. doi: 10.1001/jamaoncol.2025.5144. Online ahead of print.NIHMS2113693
Year
2025
Research Committee(s)
Gastrointestinal
PMID
PMID41343176
PMC
PMC12679421
Study Number(s)
CTSU/C80702

Summary from the NCI clinical trials planning meeting on next generation of clinical trials in non-muscle invasive bladder cancer()

Authors
Apolo A
Journal / Conference
Bladder Cancer. 2025 Feb 24;11(1):23523735251319185. doi: 10.1177/23523735251319185. eCollection 2025 Jan-Mar.
Year
2025
Research Committee(s)
Genitourinary
PMID
PMID40034245
PMC
PMC11863732
Study Number(s)
S1806

Impact of Testosterone Recovery on Oncologic Outcomes in High-Risk, Localized Prostate Cancer

Authors
Hunt TC
Journal / Conference
Prostate. 2025 Dec;85(16):1522-1530. doi: 10.1002/pros.70043. Epub 2025 Sep 9.
Year
2025
Research Committee(s)
Genitourinary
PMID
PMID40926427
Study Number(s)
CTSU/C90203, S9921

Clinical Validity of Repeated Circulating Tumor Cell Enumeration as an Early Treatment Monitoring Tool for Metastatic Breast Cancer in the PREDICT Global Pooled Analysis

Authors
Janni W
Journal / Conference
Clin Cancer Res. 2025 Jun 3;31(11):2196-2209. doi: 10.1158/1078-0432.CCR-24-3108
Year
2025
Research Committee(s)
Breast
PMID
PMID40100138
PMC
PMC12130808
Study Number(s)
S0500

Novel clinical trial designs emerging from the molecular reclassification of cancer

Authors
Nikanjam M
Journal / Conference
CA Cancer J Clin. 2025 May-Jun;75(3):243-267. doi: 10.3322/caac.21880. Epub 2025 Jan 22.NIHMS2049643
Year
2025
Research Committee(s)
Early Therapeutics and Rare Cancers
PMID
PMID39841128
PMC
PMC12061631
Study Number(s)
S1609

Assessing Health Information Seeking Behaviors Among Targeted Social Media Users Using an Infotainment Video About a Cancer Clinical Trial: Population-Based Descriptive Study

Authors
Sommers J
Journal / Conference
JMIR Cancer. 2025 Mar 3;11:e56098. doi: 10.2196/56098
Year
2025
PMID
PMID40029972
PMC
PMC11892945

ASO Author Reflections: Reasonable Doubt: The Case for Somatostatin Analogs in Pancreas Surgery Remains Unsettled

Authors
Goodsell KE
Journal / Conference
Ann Surg Oncol. 2025 Oct;32(10):7459-7460. doi: 10.1245/s10434-025-17730-x. Epub 2025 Jun 23.
Year
2025
Research Committee(s)
Palliative Care
PMID
PMID40549085
Study Number(s)
S2408

If it is a solid tumor target, then it may be a hematologic cancer target: Bridging the great divide

Authors
Adashek JJ
Journal / Conference
Med. 2025 Jan 10;6(1):100550. doi: 10.1016/j.medj.2024.11.003. Epub 2024 Dec 16.NIHMS2033552
Year
2025
Research Committee(s)
Early Therapeutics and Rare Cancers
PMID
PMID39689708
PMC
PMC11725447

Tumour-agnostic kinase inhibitors

Authors
Adashek JJ
Journal / Conference
Nat Rev Drug Discov. 2025 Jul;24(7):504-520. doi: 10.1038/s41573-025-01147-y. Epub 2025 Mar 6.NIHMS2077643
Year
2025
Research Committee(s)
Early Therapeutics and Rare Cancers
PMID
PMID40050521
PMC
PMC12221794

Lessons learned from a decade of immune checkpoint inhibition: The good, the bad, and the ugly

Authors
Adashek JJ
Journal / Conference
Cancer Metastasis Rev. 2025 Apr 4;44(2):43. doi: 10.1007/s10555-025-10260-8
Year
2025
Research Committee(s)
Early Therapeutics and Rare Cancers
PMID
PMID40183852
PMC
PMC11971148